Valuation Models Flag Mixed Signals Across Stocks

Valuation Screens Spotlight Diverging Opportunities

A series of new Simply Wall St analyses released on 1 February 2026 outline contrasting valuation pictures across several listed companies, using discounted cash flow (DCF), excess returns and relative multiple frameworks. While some names appear materially undervalued on cash flow and earnings-based models, others screen as potentially overvalued when current prices are compared with implied fair values.

The reports also emphasise how sector positioning and recent share price performance shape investor focus, with valuation scorecards and proprietary “Fair Ratio” estimates used to benchmark stocks against industry and peer averages.

Cenovus Energy Leads on DCF-Implied Discount

Cenovus Energy stands out with one of the largest DCF-derived discounts. A two-stage Free Cash Flow to Equity model, using last twelve month free cash flow of about CA$3.27 billion and projections out to 2035, produces an estimated intrinsic value of CA$108.49 per share. Against a recent share price of CA$26.87, the analysis suggests Cenovus is undervalued by 75.2% on this measure.

Cenovus carries a valuation score of 4 out of 6, indicating it screens as undervalued on most of the checks applied. The stock has returned 4.5% over the past week, 11.7% over the past month and year to date, and 32.6% over the past year. On earnings, Cenovus trades at a P/E of 16.24x, in line with the Oil and Gas industry average and below a peer group average of 19.62x. Simply Wall St’s Fair Ratio P/E of 19.59x implies the shares are undervalued on this metric as well.

Envista Holdings and Verra Mobility Also Screen Undervalued on Cash Flows

Envista Holdings and Verra Mobility also register sizeable DCF-based discounts. Envista’s two-stage Free Cash Flow to Equity model, anchored on latest twelve month free cash flow of about US$253.1 million and forecasts through 2035, yields an intrinsic value estimate of US$34.21 per share. With the stock at US$23.47, the DCF output implies a 31.4% discount.

Envista carries a valuation score of 5 out of 6. Its shares have fallen 1.6% over the last week but are up 8.2% over the past month and year to date, and 14.4% over the past year, while three- and five-year returns remain negative. On a price-to-sales basis, Envista trades at 1.47x, below both the Medical Equipment industry average of 3.21x and a peer average of 1.90x. A Fair Ratio P/S of 1.80x suggests the stock may be trading below a model-based fair multiple.

Verra Mobility’s DCF, also using a two-stage Free Cash Flow to Equity approach, points to an intrinsic value of US$41.65 per share. Based on a recent price of US$19.30, the stock appears 53.7% undervalued on this metric. The company posts a valuation score of 3 out of 6, with three checks flagging undervaluation.

However, Verra Mobility’s earnings multiple paints a different picture. The shares trade on a P/E of 60.27x, compared with a Professional Services industry average of 23.33x and a peer group average of 20.35x. A Fair Ratio P/E of 33.48x implies the current multiple is above what that framework supports. The stock has declined 9.5% over seven days, 13.6% over 30 days and year to date, and 26.9% over 12 months, though three- and five-year returns remain positive.

Valley National Bancorp and Carlyle Group Show Opposing Excess Returns Signals

Excess returns modelling for Valley National Bancorp suggests the regional bank may be undervalued. Using a starting book value of US$13.39 per share, a stable EPS estimate of US$1.47 and an average return on equity of 9.84% versus a cost of equity of US$1.06 per share, the model estimates intrinsic value at US$25.43 per share. This compares with a recent share price of US$12.46, implying the stock is 51.0% undervalued on this basis.

Valley National’s valuation score stands at 4 out of 6. The shares have gained 4.6% over seven days, 6.6% over 30 days and year to date, 26.8% over one year, 15.2% over three years and 39.1% over five years. On a P/E basis, Valley National trades at 12.19x, above the broader Banks industry average of 11.75x but below a peer group average of 15.40x. A Fair Ratio P/E of 14.75x indicates the current multiple is below this tailored estimate, supporting the undervaluation conclusion from that framework.

By contrast, Carlyle Group’s excess returns analysis points to potential overvaluation. Starting from a book value of US$15.60 per share and a stable EPS of US$1.97, with an average return on equity of 12.53% and a cost of equity of US$1.49 per share, the model estimates intrinsic value at about US$23.40 per share. Compared with a recent share price of US$58.78, this implies Carlyle is 151.2% overvalued on this metric. The stock scores 1 out of 6 on the valuation checks applied.

Carlyle’s shares have risen 7.5% over the past year but have declined 3.4% over the past month and 4.1% over the past week. The company trades on a P/E of 32.03x, above the Capital Markets industry average of 23.62x but below a peer group average of 54.02x. A Fair Ratio P/E estimate of 18.83x suggests the shares are trading above the level implied by that model, reinforcing the excess returns signal.

Dorian LPG: Strong Momentum with Modest Valuation Gap

Dorian LPG has attracted attention after robust price performance alongside a smaller implied discount. The shares, trading at US$29.53, show a year-to-date return of 19.3% and a one-year total return of 35.0%. A 21.32% gain over the past month compares with a 2.36% three-month return, while the five-year total shareholder return stands at 381.35%.

The most followed community narrative on Simply Wall St assigns Dorian LPG a fair value of US$32.00 per share, indicating the stock is about 7.7% undervalued against its last close. That view incorporates assumptions around shipping volumes, margin resilience and capital allocation, as well as the company’s investments in fleet energy efficiency, retrofits for ammonia carriage and early compliance with International Maritime Organization decarbonisation targets.